Management ChangeJul 6, 2026, 04:06 PM
Longeveron Appoints Marie Washburn as New CFO
AI Summary
Longeveron Inc. announced the appointment of Marie Washburn as its new Senior Vice President and Chief Financial Officer, effective July 13, 2026. Ms. Washburn, who previously served as the company's Vice President and Corporate Controller, brings over 20 years of experience in the pharmaceutical and biotech sectors. She succeeds Lisa Locklear, who is departing to pursue other professional and personal interests. The company also highlighted its focus on the upcoming top-line results from its Phase 2b clinical trial for Hypoplastic Left Heart Syndrome (HLHS), anticipated in the third quarter of 2026.
Key Highlights
- Marie Washburn appointed Senior Vice President and Chief Financial Officer (CFO).
- Appointment effective July 13, 2026.
- Ms. Washburn previously served as the Company’s Vice President and Corporate Controller since November 2025.
- She succeeds Lisa Locklear, who is stepping down to pursue other opportunities.
- Company anticipates top-line results from its Phase 2b clinical trial for HLHS in Q3 2026.
Price Impact
More from LGVN